Related Experiment Video
Updated: May 9, 2026
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGFβ-pathway is down-regulated in a uterine carcinosarcoma: a case study
Andrzej Semczuk1, Piotr K Zakrzewski, Ewa Forma
1IInd Department of Gynecology, Lublin Medical University, Lublin, Poland.
Abstract:
Data assessing the role of various genetic alterations in uterine carcinosarcoma (CS), particularly the transforming growth factors-β (TGFβ) that play a crucial role in many cellular processes, including proliferation, differentiation, adhesion and migration, are scarce. TGFβ exert their effects through specific receptors and associated auxiliary receptors. In the current study, we investigated the expression of TGFβ isoforms and their receptors, as well as selected genes in a case of CS. We applied the real-time fluorescence detection PCR method with FAM dye-labeled TaqMan specific probes. In a comparison to the normal counterpart, TGFB1, TGFB2, TGFBRII, TGFBR3, ENG and CD109 were all down-regulated in uterine CS samples at different extents. BIRC5 and hTERT, markers of tumor survival, were up-regulated in CS as compared with normal counterparts. A concomitant increase of the hypoxia marker HIF1A expression pattern was noted, whereas the expression of GPR120, responsible for free fatty acids sensing, was not different in both counterparts evaluated. In conclusion, deregulation of various cellular mechanisms in uterine CS is associated with alterations at many levels - cell growth and proliferation, apoptosis, and impaired response to stimuli from extracellular environment.
Insights
This study reveals significant genetic alterations in uterine carcinosarcoma (CS), with down-regulation of transforming growth factors-β (TGFβ) and related genes. Key tumor survival markers like BIRC5 and hTERT were up-regulated, indicating complex cellular deregulation in CS.
Area of Science:
- Gynecologic Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Uterine carcinosarcoma (CS) is a rare and aggressive malignancy.
- The role of genetic alterations, particularly transforming growth factors-β (TGFβ) signaling, in CS pathogenesis is not well understood.
- TGFβ signaling is critical for cellular processes including proliferation, differentiation, adhesion, and migration.
Observation:
- This study investigated the expression of TGFβ isoforms, their receptors, and other selected genes in uterine CS.
- Real-time fluorescence detection PCR with TaqMan probes was employed for gene expression analysis.
- Gene expression was compared between CS tissues and normal counterparts.
Findings:
- Transforming growth factors-β (TGFB1, TGFB2), their receptors (TGFBRII, TGFBR3), and adhesion molecules (ENG, CD109) were significantly down-regulated in CS.
- Tumor survival markers (BIRC5, hTERT) and the hypoxia marker (HIF1A) were up-regulated in CS compared to normal tissues.
- GPR120, involved in fatty acid sensing, showed no significant difference between CS and normal tissues.
Implications:
- The findings suggest widespread deregulation of cellular mechanisms in uterine CS, affecting cell growth, proliferation, apoptosis, and environmental response.
- Alterations in TGFβ signaling and other pathways contribute to the aggressive nature of CS.
- Further research into these genetic alterations may reveal novel therapeutic targets for uterine carcinosarcoma.
Related Concept Videos
01:16TGF - β Signaling Pathway
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...